Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies

by Andrea Tubaro, José E. Batista, Victor W. Nitti, Sender Herschorn, Christopher R. Chapple, Mary Beth Blauwet, Emad Siddiqui, Moses Huang, Matthias Oelke
Published 2017-06-01

Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease

by Gregory Vurture, Benoit Peyronnet, Jose-Alberto Palma, Rachael D. Sussman, Dominique R. Malacarne, Andrew Feigin, Ricardo Palmerola, Nirit Rosenblum, Steven Frucht, Horacio Kaufmann, Victor W. Nitti, Benjamin M. Brucker
Published 2019-09-01

Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson's disease

by Cristiano M. Gomes, Zein M. Sammour, Jose de Bessa Junior, Egberto R. Barbosa, Roberto I. Lopes, Flávio S. Sallem, Flavio E. Trigo-Rocha, Homero Bruschini, Victor W. Nitti, Miguel Srougi
Published 2014-01-01